Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic. - Kimura, Sakiko; Katsuya, Hiroo; Nakashima, Chiho; Sueoka-Aragane, Naoko; Hayashida, Koji; Sasaki, Kazumi; Sogawa, Rintaro; Furuno, Tatsuya; Yamauchi, Moriyasu; Sugiyama, Yoichiro; Noshiro, Hirokazu; Esaki, Motohiro; et al. (BMC Immunology, 2025)